000250 — Sam Chun Dang Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Market Cap
KR₩5tn
Enterprise Value
KR₩5tn
Revenue
KR₩211bn

Annual balance sheet for Sam Chun Dang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Interim Report	Interim Report	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	96,966	97,025	86,248	92,744	134,917
Net Total Accounts Receivable
Net Total Receivables	36,540	38,589	39,004	35,111	61,387
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	166,528	168,920	157,749	163,906	242,532
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	63,276	74,112	87,212	90,009	103,595
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	317,079	345,997	372,793	408,022	519,772
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,658	54,081	38,160	57,957	93,421
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	130,453	171,902	199,052	187,523	253,667
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	186,626	174,095	173,741	220,499	266,105
Total Liabilities & Shareholders' Equity	317,079	345,997	372,793	408,022	519,772
Total Common Shares Outstanding